EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy

Gianni Ghetti iD, Francesco Saverio Mennini, Andrea Marcellusi, Matthias Bischof, Gabriele Maria Pistillo, Marika Pane

Clinical Drug Investigation · 2024-09 · 44 (9) · 687-701

DOI: 10.1007/s40261-024-01386-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Drug Investigation, online erschienen am 22.08.2024. Verfasst von Gianni Ghetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: AdRes HEOR s.r.l., Via Vittorio Alfieri, 17, 10121, Turin, Italy. g.ghetti@adreshe.com. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Neonatal Screening, Muscular Atrophy, Spinal, Quality-Adjusted Life Years. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novartis Gene Therapies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisNeonatal ScreeningMuscular Atrophy, SpinalQuality-Adjusted Life YearsHumansInfant, NewbornItalyHealth Care CostsDecision Support TechniquesCost-Effectiveness Analysis

Autor:innen und Institutionen

  • AdRes HEOR s.r.l., Via Vittorio Alfieri, 17, 10121, Turin, Italy. g.ghetti@adreshe.com.
  • CEIS-Economic Evaluation and HTA (EEHTA), Faculty of Economics, University of Rome "Tor Vergata", Rome, Italy.
  • Institute for Leadership and Management in Health, Kingston University London, London, UK.
  • Novartis Gene Therapies GmbH, Rotkreuz, Switzerland.
  • Novartis Gene Therapies, Milan, Italy.
  • Pediatric Neurology Unit, Fondazione Policlinico Universitario "A. Gemelli," IRCCS, Rome, Italy.

ORCID-Profile: Gianni Ghetti

Förderung

  • Novartis Gene Therapies

Zitieren

APA

Ghetti, G., Mennini, F. S., Marcellusi, A., Bischof, M., Pistillo, G. M., & Pane, M. (2024). Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy. Clinical Drug Investigation, 44(9), 687-701. https://doi.org/10.1007/s40261-024-01386-8

Vancouver

Ghetti G, Mennini FS, Marcellusi A, Bischof M, Pistillo GM, Pane M. Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy. Clinical Drug Investigation. 2024;44(9):687-701. doi:10.1007/s40261-024-01386-8

BibTeX
@article{Ghetti2024,
  author = {Ghetti, Gianni and Mennini, Francesco Saverio and Marcellusi, Andrea and Bischof, Matthias and Pistillo, Gabriele Maria and Pane, Marika},
  title = {Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy},
  journal = {Clinical Drug Investigation},
  year = {2024},
  volume = {44},
  number = {9},
  pages = {687--701},
  doi = {10.1007/s40261-024-01386-8}
}
Kostenlos starten →